Given the pleiotropic anti-tumoral role of HO-1 in PCa, in this work, we set out to evaluate whether HO-1 interacted with proteins previously described with nuclear localization, enabling it to reprogram prostate tumor cells fate, favoring the acquisition of a less aggressive phenotype. This evidence concerns the gene HMOX1 and prostate neoplasm.